This is in line with our previous observation that, in a model of MPO-ANCA-associated vasculitis, repertaxin treated mice were not protected from hematuria, albuminuria or glomerular crescent formation. The gene discussed is MPO; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.